All In Biotech

Drug Trial Radar · NCT02473640

A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

A Phase 1b/2a, Multi-Center, Open-Label, 2-Period, Fixed-Sequence Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Healthy Adult Subjects With a Functioning Ileostomy

Last checked: Nov 19, 2026Latest source record: Nov 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Jun 2015

Primary completion

Apr 2016

Study completion Apr 2016

Sponsor

Lead sponsor
Theriva Biologics, Inc.Industry
Sponsor type
Industry
First posted
Jun 16, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Phase 1b/2a, Multi-Center, Open-Label, 2-Period, Fixed-Sequence Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Healthy Adult Subjects with a Functioning Ileostomy

Conditions

  • Healthy Volunteers With Ileostomy

Interventions

  • SYN-004Drug

  • EsomeprazoleDrug

  • CeftriaxoneDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ceftriaxone Concentration in Intestinal Chyme Period 1Time frame: 0-8.5 hours
  2. Ribaxamase Concentration in Intestinal Chyme Period 1Time frame: 0-8.5 hours
  3. Ceftriaxone Concentration in Intestinal Chyme Period 2Time frame: 0-8.5 hours
  4. Ribaxamase Concentration in Intestinal Chyme Period 2Time frame: 0-8.5 hours

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Synthetic Biologics Investigative Site

    Montreal, Canada

  • Synthetic Biologics Investigative Site

    Edmonton, Alberta, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.